HALIX is a Healthcare CDMO specializing in biopharmaceuticals, including recombinant proteins and antibodies, viral vectors and vaccines. With state-of-the-art GMP manufacturing facilities in Leiden Bio Science Park, we support pharmaceutical companies worldwide with the development & commercialization of biologics enabling the treatment & prevention of life threatening conditions such as cancer, COVID-19, influenza and other infectious diseases. At HALIX, we are committed to delivering cutting-edge solutions, fostering meaningful partnerships, and upholding our promise to drive impact in the biotech and healthcare industries with quality, compliance, and sustainability at the heart of every process.
Looking for a particular HALIX B.V. employee's phone or email?
The HALIX B.V. annual revenue was $12.9 million in 2026.
Daan Bormans is the COO of HALIX B.V..
49 people are employed at HALIX B.V..
The NAICS codes for HALIX B.V. are [541711, 541, 5417, 54171, 54].
The SIC codes for HALIX B.V. are [283, 28, 80].